Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 5
Submit an article Journal homepage
471
Views
4
CrossRef citations to date
0
Altmetric
Systematic review and meta-analysis

Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis

Gonçalo Martins e Pereiraa Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, PortugalORCID Iconhttps://orcid.org/0000-0003-3297-9586View further author information
ORCID Icon,
Gonçalo S. Duarteb Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;c Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;d Faculdade de Medicina, Centro de Estudos de Medicina Baseada na Evidência, Universidade de Lisboa, Lisboa, PortugalView further author information
,
Vasyl Katerenchuka Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, PortugalView further author information
,
João Costab Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;c Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;d Faculdade de Medicina, Centro de Estudos de Medicina Baseada na Evidência, Universidade de Lisboa, Lisboa, PortugalView further author information
,
Cláudio Davidb Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;c Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;e Serviço de Cardiologia, Hospital Universitário de Santa Maria (CHULN), CAML, Centro Cardiovascular da Universidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, PortugalView further author information
,
Joaquim J. Ferreirab Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;c Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;f CNS-Campus Neurológico Sénior, Torres Vedras, PortugalORCID Iconhttps://orcid.org/0000-0003-3950-5113View further author information
ORCID Icon,
Fausto J. Pintoe Serviço de Cardiologia, Hospital Universitário de Santa Maria (CHULN), CAML, Centro Cardiovascular da Universidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, PortugalView further author information
&
Daniel Caldeirab Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;c Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, Portugal;e Serviço de Cardiologia, Hospital Universitário de Santa Maria (CHULN), CAML, Centro Cardiovascular da Universidade de Lisboa - CCUL, Faculdade de Medicina, Universidade de Lisboa. Avenida Professor Egas Moniz, Lisboa, PortugalCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2520-5673View further author information
ORCID Icon show all
Pages 577-588 | Received 09 Sep 2020, Accepted 14 Jan 2021, Published online: 27 Jan 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Emanuel Raschi, Igor Diemberger, Mario Sabatino, Elisabetta Poluzzi, Fabrizio De Ponti & Luciano Potena. (2022) Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction. Expert Opinion on Pharmacotherapy 23:3, pages 303-320.
Read now
Luis Fernando Valladales-Restrepo, Nicolás Sánchez-Ramírez, Andrés Felipe Usma-Valencia, Santiago Velásquez-Quirama, Manuela Henao-Martínez, Jorge Alejandro Castro-Rodriguez, Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque & Jorge Enrique Machado-Alba. Use of sacubitril/valsartan in patients with heart failure: evidence from the real world. Expert Opinion on Pharmacotherapy 0:0, pages 1-9.
Read now

Articles from other publishers (2)

Yaling Zhang, Xiaoyu Zhao, Hao Huang & Ming Li. (2022) Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension. Clinical Research in Cardiology 112:7, pages 855-867.
Crossref
Chengchun Zuo, Xiaoye Li, Linlin Fan, Jing Li, Dan Tian, Can Chen, Xiaoyu Li & Qianzhou Lv. (2022) Effectiveness and safety of sacubitril/valsartan for patients with hypertension and heart failure in the real‐world setting: A retrospective study in China . Journal of Clinical Pharmacy and Therapeutics 47:10, pages 1539-1547.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.